Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
ceo and founder Processed

Peter Forsell & Implantica

2 shared events · Importance 3 · Last updated Aug 25, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard

Peter Forsell is the founder and current CEO of Implantica, a medical technology company he established in 2003. He holds a controlling equity stake and is the driving force behind the company's strategic direction and product development.

89
Regulatory
Peter Forsell: Peter Forsell, CEO and founder, is the key executive driving the company's strategy and public communications around the FDA approval and U.S. launch.
Implantica: Implantica is the central company receiving FDA approval for its lead product RefluxStop, enabling U.S. market entry and representing a major growth milestone.
Aug 20, 2026 · 32 articles
77
Business
Peter Forsell: Peter Forsell, CEO of Implantica, is scheduled to speak at the Q2 2026 presentation, representing the company's leadership and discussing results.
Implantica: Implantica is the company hosting the Q2 2026 earnings presentation. The event provides an opportunity for the company to communicate its financial results and strategic progress to investors.
Aug 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Peter Forsell and Implantica interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.